Ground Swell Capital’s Verrica Pharmaceuticals VRCA Stock Holding History

Ground Swell Capital’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,053	Closed	-$7.37K	–	266
2024 Q4	$7.37K	Buy	+1,053	New	+$11.6K	0.01%	140
2022 Q3	–	Sell	-1,021	Closed	-$20K	–	190
2022 Q2	$20K	Buy	+1,021	New	+$51.3K	0.04%	110

Other funds holding VRCA

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return

Ground Swell Capital's VRCA Position: Q1 2025 in Review

Ground Swell Capital sold out of Verrica Pharmaceuticals (VRCA) in Q1 2025, closing a stake of 1,053 shares — an estimated $7.37K sold.

Ground Swell Capital first reported a position in VRCA in Q2 2022 and held it in 2 quarters. The position peaked at $20K in Q2 2022. 74 funds tracked by Wall St. Rank hold VRCA as of Q1 2025.

Ground Swell Capital reported no remaining Verrica Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Ground Swell Capital sold 1,053 Verrica Pharmaceuticals shares in Q1 2025, an estimated $7.37K.
Ground Swell Capital first reported a position in Verrica Pharmaceuticals in Q2 2022 and held it in 2 quarters.
Ground Swell Capital's Verrica Pharmaceuticals position peaked at $20K in Q2 2022.
74 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2025.

Based on Ground Swell Capital's 13F filing for Q1 2025, filed 13 May 2025.